Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia (Q77769230)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

8

van Rhee F

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Singhal S

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Powles R

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Henslee-Downey PJ

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Chiang KY

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Treleaven J

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Godder K

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Kulkarni S

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Sirohi B

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Pinkerton CR

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Meller S

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Mehta J

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

291-295

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896425%20AND%20SRC:MED&resulttype=core&format=json

The impact of karyotype on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapy

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703373

7 January 2021

Allogeneic bone marrow transplantation for acute leukemia refractory to induction chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703373

7 January 2021

Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703373

7 January 2021

Allogeneic bone marrow transplantation from partially mismatched related donors as therapy for primary induction failure acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703373

7 January 2021

Graft-versus-leukemia reactions in clinical bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703373

7 January 2021

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703373

7 January 2021

A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703373

7 January 2021

Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703373

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703373

7 January 2021